Exclusive

Publication

Byline

Clinical Trial: Photobiomodulation Effects on Blood Pressure and Vascular Function in Treated Hypertensive Patients

U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07525310) titled 'Photobiomodulation Effects on Blood Pressure and Vascular Function in Treated Hypertensive... Read More


Clinical Trial: Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK Inhibitors

U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07526597) titled 'Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK Inh... Read More


Clinical Trial: Chinese, Overweight or Obesity, Real-World Registry Study

U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07525037) titled 'Chinese, Overweight or Obesity, Real-World Registry Study' on March 18. Brief Summary: Th... Read More


Clinical Trial: Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma

U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07523737) titled 'Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Prim... Read More


Clinical Trial: A Phase II Clinical Study to Evaluate the Efficacy and Safety of NS-136 in the Treatment of Schizophrenia

U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07521683) titled 'A Phase II Clinical Study to Evaluate the Efficacy and Safety of NS-136 in the Treatment o... Read More


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 14 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More


Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More